What we’re doing

Current influence and advocacy work

Access to Treatment

Men with prostate cancer need equal access to the effective treatments, regardless of what province they live in. That’s not always the case today. We will change that with the help of men, families and clinicians who provide their personal and professional experience to enhance drug review processes.
Key areas:
  • Ensure all provincial health plans fund life-saving drugs and treatments
  • Ensure men in every province have the same access to these drugs

Here’s how we make a difference - together:

Fighting for access to drugs

After consultations, Health Canada approved ERLEADA (Apalutamide) an oral treatment for men with non-metastatic castration-resistant prostate cancer. This was a crucial step in offering men with this type of advanced cancer a treatment option for the first time, and in changing their outcomes.
How did Prostate Cancer Canada help?

We made sure patient and clinician voices, experiences and opinions were heard throughout the decision-making process

Lobbying for PSA test funding in British Columbia and Ontario

The PSA test cost is covered by the government for asymptomatic men everywhere in Canada except British Columbia and Ontario when ordered by a doctor. This needs to change. All men need access to this vital test, which is the first step to early diagnosis. The out-of-pocket cost is a barrier for many families. This means the men may not be accessing potentially life-saving information about their health.
When prostate cancer is caught early, survival is close to 100%. We call on the governments of British Columbia and Ontario to remove this barrier to early diagnosis. We are continuing to work with these provinces to ensure fair and equal coverage for this important test.
Do you live in British Columbia or Ontario and want to get involved in advocating for PSA test coverage? Email advocacy@prostatecancer.ca to learn how.

Take action


Learn more about upcoming opportunities to lend your voice and take action.

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive